EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Immunoglobulin G and Complement as Major Players in the Neurodegeneration of Multiple Sclerosis

Peter G E Kennedy iD, Matthew Fultz, Jeremiah Phares, Xiaoli Yu iD

Biomolecules · 2024

DOI: 10.3390/biom14101210 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Biomolecules, 2024. Verfasst von Peter G E Kennedy und 3 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Neuroscience and Psychology, University of Glasgow, Glasgow G61 1QH, UK. Hauptthemen laut MEDLINE: Multiple Sclerosis, Immunoglobulin G. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 106 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIH HHS, NIH NIMH.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Multiple Sclerosis (MS) is an inflammatory, demyelinating, and neurodegenerative disease of the central nervous system (CNS) and is termed as one of the most common causes of neurological disability in young adults. Axonal loss and neuronal cell damage are the primary causes of disease progression and disability. Yet, little is known about the mechanism of neurodegeneration in the disease, a limitation that impairs the development of more effective treatments for progressive MS. MS is characterized by the presence of oligoclonal bands and raised levels of immunoglobulins in the CNS. The role of complement in the demyelinating process has been detected in both experimental animal models of MS and within the CNS of affected MS patients. Furthermore, both IgG antibodies and complement activation can be detected in the demyelinating plaques and cortical gray matter lesions. We propose here that both immunoglobulins and complement play an active role in the neurodegenerative process of MS. We hypothesize that the increased CNS IgG antibodies form IgG aggregates and bind complement C1q with high affinity, activating the classical complement pathway. This results in neuronal cell damage, which leads to neurodegeneration and demyelination in MS.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Multiple SclerosisImmunoglobulin GHumansAnimalsComplement System ProteinsComplement ActivationComplement C1qNeurodegenerative Diseases

Stichwörter der Autor:innen

IgGcomplementdisease progressionmultiple sclerosisneurodegenerationneurons

Substanzen

Immunoglobulin GComplement System ProteinsComplement C1q

Autor:innen und Institutionen

  • Institute of Neuroscience and Psychology, University of Glasgow, Glasgow G61 1QH, UK.
  • Department of Neurosurgery, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA.

ORCID-Profile: Peter G E Kennedy, Xiaoli Yu

Förderung

  • NIH HHS
  • NIH NIMH

Zitieren

APA

Kennedy, P. G. E., Fultz, M., Phares, J., & Yu, X. (2024). Immunoglobulin G and Complement as Major Players in the Neurodegeneration of Multiple Sclerosis. Biomolecules. https://doi.org/10.3390/biom14101210

Vancouver

Kennedy PGE, Fultz M, Phares J, Yu X. Immunoglobulin G and Complement as Major Players in the Neurodegeneration of Multiple Sclerosis. Biomolecules. 2024. doi:10.3390/biom14101210

BibTeX
@article{Kennedy2024,
  author = {Kennedy, Peter G E and Fultz, Matthew and Phares, Jeremiah and Yu, Xiaoli},
  title = {Immunoglobulin G and Complement as Major Players in the Neurodegeneration of Multiple Sclerosis},
  journal = {Biomolecules},
  year = {2024},
  doi = {10.3390/biom14101210}
}
Kostenlos starten →